All News

Recent surveys have found high rates of occupational burnout among hematology and oncology pharmacists, with more than half or survey respondents reporting burnout.

Matthew Harms, a medical consultant and care center director at the MDA and associate professor of neurology at Columbia University Medical Center, to discuss new treatments and anticipated developments for ALS over the next year.

The technology demonstrates the important role students can play in pushing the pharmaceutical industry forward.

Blood eosinophil counts and FeNO levels are 2 key inflammatory biomarkers used by clinicians to inform treatment options and were defined as blood eosinophil count and FeNO.

The norepinephrine reuptake inhibitor indicated for patients aged age 6 to 17 years recently received FDA approval.

The primary endpoint of organ failure or death was 11.2% for those receiving dapagliflozin compared to 13.8% for those receiving the placebo.

A combination immunotherapy of interleukin-21 (IL-21) and interferon alpha (IFN-alpha) in combination with antiretroviral therapy (ART) is effective in generating highly functional natural killer (NK) cells that can help control and reduce simian immunodeficiency virus (SIV) in animal models.

Smart agent systems designed to automate insulin dose selection for critically ill patients could potentially optimize the safety and efficiency of insulin infusion practices in intensive care unit settings, according to a study published in BMJ Quality & Safety.

Heart failure can involve multiple factors, but heart muscle scarring is thought to be an important contributing factor in up to two-thirds of patients with HFpEF.

Pharmacy Times® spoke with Tomas Villanueva, DO, MBA, FACPE, SFHM, practicing health care provider, and associate vice president for clinical resources at Vizient, about vaccine hesitancy among health care workers.

Digital tools can help pharmacists and other health care providers ensure effective and safe drug use.

In a recent Student Café series, we asked students at the Washington State University (WSU) College of Pharmacy and Pharmaceutical Sciences what drew them to study at WSU.

The most common symptom of patients seeking evaluation for post-COVID-19 syndrome was fatigue.

Collaboration with academic centers expands clinical services to help support health care goals.

As accessible health care providers with links to all facets of the health care system, pharmacists are perfectly positioned to organize COVID-19 vaccine distribution in their communities.

Pairing semaglutide, a drug used to treat diabetes, with a minimally invasive endoscopic sleeve gastroplasty (ESG) can provide significant weight loss benefits for patients who are not candidates for invasive weight loss surgery, according to a study presented at Digestive Disease Week 2021.

Supplies of the critical rescue medication for asthma attacks were close to depleted at many hospitals amid COVID-19.

If half of the US population is vaccinated by the summer rather than the fall, 5.8 million cases of COVID-19 could be prevented.

The study authors sought to examine prescription drug and health care use after SARS-CoV-2 infection not requiring hospital admission.

The incidence of colorectal cancer in adults between the ages of 40 and 49 years has increased by nearly 15% since 2000.

Located in Bangor, Maine, the Husson University School of Pharmacy offers unique programs that have helped shape pharmacy practice in the state of Maine.

According to the US Department of Health and Human Services Office of Minority Health, Asian Americans are 40% more likely to be diagnosed with diabetes and 60% more likely to be diagnosed with renal disease compared to non-Hispanic whites.

Supplements for Omega-3s often contain both EPA and DHA.

Study participants who fasted 2 days per week reported fewer scaling and thickening, with 30% also reporting a decrease in itching associated with psoriasis.

But in real-world situations, such as when a bystander administers naloxone, there are gray areas.

Notification letters were sent Monday to manufacturers found to violate 340B pricing after a review of the manufacturers’ actions and an analysis of complaints received from covered entities.

Data from the phase 3 VOYAGER PAD study demonstrated that rivaroxaban at 2.5 mg twice daily in combination with aspirin at 100 mg once daily was able to reduce severe vascular events in patients with PAD.

Patient engagement programs should continually evolve in order to meet patient needs and behaviors.

Exercise, nutrition, sleep, and supplements can help slow cognitive decline in older individuals.

The American Association of Colleges of Pharmacy (AACP) is recognizing the University of Connecticut, 5 individuals, and a scholarly paper for their achievements, as recipients of its top awards.